High-intensity interval training induces beneficial effects on coronary atheromatous plaques: a randomized trial

European Journal of Preventive Cardiology

23 December 2022
Organised by: Logo
ESC Journals CORONARY ARTERY DISEASE, ACUTE CORONARY SYNDROMES, ACUTE CARDIAC CARE IMAGING Imaging - Other Interventional Cardiology PREVENTIVE CARDIOLOGY Rehabilitation and Sports Cardiology Risk Factors and Prevention

Abstract

AbstractAims

Coronary atheroma volume is associated with risk of coronary events in coronary artery disease (CAD). Exercise training is a cornerstone in primary and secondary prevention of CAD, but the effect of exercise on coronary atheromatous plaques is largely unknown. We assessed the effect of 6 months supervised high-intensity interval training (HIIT) on coronary plaque geometry using intravascular ultrasound in patients with stable CAD following percutaneous coronary intervention (PCI).

Methods and results

Sixty patients were randomized to two sessions of weekly supervised HIIT at 85–95% of peak heart rate (n = 30) or to follow contemporary preventive guidelines (control group, n = 30). The study endpoints were change in percent atheroma volume (PAV) and total atheroma volume (TAV) normalized for segment length (TAVnorm) at 6-month follow-up. The change in average PAV for matched coronary segments from baseline to follow-up showed a significant between-group difference (−1.4, 95% CI: −2.7 to −0.1, P = 0.036). There was a significant reduction in the HIIT group (−1.2, 95% CI: −2.1 to −0.2, P = 0.017) while not in the control group (0.2, 95% CI: −0.7 to 1.1, P = 0.616). TAVnorm was reduced (−9 mm3, 95% CI: −14.7 to −3.4, P = 0.002) after HIIT, with a significant between-group difference (−12.0 mm3, 95% CI: −19.9 to −4.2, P = 0.003).

Conclusion

In patients with established CAD, a regression of atheroma volume was observed in those undergoing 6 months of supervised HIIT compared with patients following contemporary preventive guidelines. Our study indicates that HIIT counteracts atherosclerotic coronary disease progression and reduces atheroma volume in residual coronary atheromatous plaques following PCI.

Contributors

Elisabeth Kleivhaug Vesterbekkmo
Elisabeth Kleivhaug Vesterbekkmo

Author

Norwegian University of Science and Technology Trondheim , Norway

ESC 365 is supported by